Your browser doesn't support javascript.
loading
T-cell Landscape in a Primary Melanoma Predicts the Survival of Patients with Metastatic Disease after Their Treatment with Dendritic Cell Vaccines.
Vasaturo, Angela; Halilovic, Altuna; Bol, Kalijn F; Verweij, Dagmar I; Blokx, Willeke A M; Punt, Cornelis J A; Groenen, Patricia J T A; van Krieken, J Han J M; Textor, Johannes; de Vries, I Jolanda M; Figdor, Carl G.
Afiliação
  • Vasaturo A; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
  • Halilovic A; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands. Department of Pathology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Bol KF; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Verweij DI; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands. Department of Pathology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Blokx WA; Department of Pathology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Punt CJ; Department of Medical Oncology, Academic Medical Centre, Amsterdam, the Netherlands.
  • Groenen PJ; Department of Pathology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • van Krieken JH; Department of Pathology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Textor J; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands. Theoretical Biology, Utrecht University, Utrecht, the Netherlands.
  • de Vries IJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands. Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Figdor CG; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands. Carl.Figdor@radboudumc.nl.
Cancer Res ; 76(12): 3496-506, 2016 06 15.
Article em En | MEDLINE | ID: mdl-27197179
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Linfócitos T / Vacinas Anticâncer / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Linfócitos T / Vacinas Anticâncer / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda